Table 2.

QT/QTc interval categorical analysis^a

	Number of subjects (%)
QTcF (ms)	Baseline (Day –1) n = 64	Placebo n = 63	Vonoprazan 40 mg n = 63	Vonoprazan 120 mg n = 64	Moxifloxacin 400 mg n = 64
>450 ms	0	0	0	0	1 (1.56)
>480 ms	0	0	0	0	0
>500 ms	0	0	0	0	0
>30 ms increase from Baseline	–	0	0	0	4 (6.25)
>60 ms increase from Baseline	–	0	0	0	0
>30 ms increase from Baseline and	–	0	0	0	0
>450 ms

QTcF, QT interval corrected by Fridericia formula.

^aResults of QTcB, QTcI, and QTcss (Supplementary Material) were consistent with that of QTcF.